Skip to main content

and
  1. Article

    Open Access

    Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

    Papillary renal cell carcinoma (pRCC) is the 2nd most frequent histological type of kidney cancer and accounts for approximately 15% of all renal cell carcinoma. It has a poorer prognosis than clear cell RCC (...

    Philippe Rochigneux, Jeanne Thomassin-Piana, Sophy Laibe, Serge Brunelle in BMC Cancer (2018)